Meta-analyse meldt 1% spijt na geslachtsoperatie, maar opgenomen studies hadden korte follow-up en veel uitval

Spijt na genderbevestigende operatie: een systematische review en meta-analyse van prevalentie

Authors
Valeria P. Bustos, Samyd S. Bustos, Andres Mascaro, Gabriel Del Corral, Antonio J. Forte, Pedro Ciudad, Esther A. Kim, Howard N. Langstein, Oscar J. Manrique
Journal
Plastic and Reconstructive Surgery Global Open
Year
2021

Summary

This review combined 27 studies of nearly 8,000 people who had gender surgery and estimated that about 1% regretted it. The authors concluded regret is extremely rare and credited better screening of patients. The 1% figure is now widely quoted. But the authors themselves say the evidence underneath is weak: most studies were rated poor or fair, almost none used tested ways of measuring regret, and results varied a lot between studies. Critics point out that people were often followed for only one or two years, while regret typically shows up after about eight years. Many people were lost track of (36% in the largest study), and some numbers were copied wrongly. Most people studied were adults treated under older, stricter rules. The 1% is best seen as a minimum drawn from incomplete data, not a reliable regret rate for today's patients.

Key findings

  • De review omvatte 27 studies over 7.928 operatiepatiënten uit 14 landen; 67% had een man-naar-vrouw-operatie en 33% vrouw-naar-man, en slechts één patiënt was geregistreerd als non-binair.
  • Gecombineerd had ongeveer 1% van de patiënten spijt van de operatie (waarschijnlijk tussen minder dan 1% en 2%), maar de resultaten verschilden sterk tussen studies; in totaal meldden 77 mensen spijt.
  • Spijt was minder dan 1% na vrouw-naar-man-operaties en borstverwijdering, 1% na man-naar-vrouw-operaties, en 2% na een operatie om een vagina te maken.
  • De meest voorkomende redenen voor spijt waren moeite om door familie en samenleving te worden geaccepteerd in de nieuwe genderrol, gevolgd door slechte chirurgische of lichamelijke resultaten.
  • Bijna alle studies gebruikten zelfgemaakte vragen of interviews, de meeste werden als slecht of redelijk van kwaliteit beoordeeld, en de follow-up liep van minder dan 1 jaar tot 9 jaar.
  • Er waren aanwijzingen dat studies met weinig spijt vaker werden gepubliceerd; correctie hiervoor verlaagde de schatting van 1% naar 0,5%.
  • Een correctie in 2022 herstelde tabellen en figuren nadat de auteurs de review opnieuw uitvoerden, en gepubliceerde brieven (Expósito-Campos & D'Angelo 2021; Bewley 2022) betwistten de methoden en conclusies.

Abstract

Background: There is an unknown percentage of transgender and gender non-confirming individuals who undergo gender-affirmation surgeries (GAS) that experiences regret. Regret could lead to physical and mental morbidity and questions the appropriateness of these procedures in selected patients. The aim of this study was to evaluate the prevalence of regret in transgender individuals who underwent GAS and evaluate associated factors.

Methods: A systematic review of several databases was conducted. Random-effects meta-analysis, meta-regression, and subgroup and sensitivity analyses were performed.

Results: A total of 27 studies, pooling 7928 transgender patients who underwent any type of GAS, were included. The pooled prevalence of regret after GAS was 1% (95% CI <1%-2%). Overall, 33% underwent transmasculine procedures and 67% transfemenine procedures. The prevalence of regret among patients undergoing transmasculine and transfemenine surgeries was <1% (IC <1%-<1%) and 1% (CI <1%-2%), respectively. A total of 77 patients regretted having had GAS. Twenty-eight had minor and 34 had major regret based on Pfäfflin's regret classification. The majority had clear regret based on Kuiper and Cohen-Kettenis classification.

Conclusions: Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.

Conclusion

Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.